Ftse Mib
33.517,81
-0,56%
DAX
18.134,16
-0,16%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
0,00%
Bitcoin
61.412,29
-0,65%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Crescita Therapeutics Inc (CTX) Crescita Therapeutics Inc (CTX) Notizie

CTX

Crescita Therapeutics (CTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:CTX
DataOraFonteTitoloSimboloCompagnia
01/06/202311:00PR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
21/01/202113:30PR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
26/11/202013:30PR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
12/11/202013:30PR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/11/202013:30PR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
12/08/202013:30PR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
28/07/202013:30PR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
27/05/202013:30PR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
14/05/202014:30PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
28/04/202023:58PR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
25/03/202000:23PR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
18/03/202012:30PR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
10/03/202014:30PR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
10/03/202014:30PR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
11/02/202013:30PR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
24/01/202013:30PR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
22/01/202013:30PR Newswire (US)Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics LoanTSX:CTXCrescita Therapeutics Inc
20/01/202013:30PR Newswire (US)Crescita Signs Exclusive Distribution Agreement with FILLMEDTSX:CTXCrescita Therapeutics Inc
07/11/201913:30PR Newswire (US)Crescita Reports 2019 Third Quarter ResultsTSX:CTXCrescita Therapeutics Inc
06/11/201900:26PR Newswire (US)U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
28/10/201912:30PR Newswire (US)Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp TopicalsTSX:CTXCrescita Therapeutics Inc
05/09/201913:00PR Newswire (Canada)Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York CityTSX:CTXCrescita Therapeutics Inc
08/08/201913:30PR Newswire (US)Crescita Reports Profitable 2019 Second Quarter ResultsTSX:CTXCrescita Therapeutics Inc
16/07/201913:30PR Newswire (Canada)United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
11/07/201913:30PR Newswire (US)Crescita Therapeutics to Host Investor Webcast on July 24, 2019TSX:CTXCrescita Therapeutics Inc
04/07/201913:30PR Newswire (Canada)Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of ...TSX:CTXCrescita Therapeutics Inc
18/06/201902:17PR Newswire (US)Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
30/05/201914:00PR Newswire (US)Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, CaliforniaTSX:CTXCrescita Therapeutics Inc
29/05/201914:00PR Newswire (US)Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications ServicesTSX:CTXCrescita Therapeutics Inc
15/05/201914:31PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:CTX

La tua Cronologia

LSE
AP27
Citi Fun 24
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network